Homepage
Medication Guide
How to Purchase Selumetinib (Koselugo)
Selumetinib (Koselugo) is a MEK1/2 kinase inhibitor specifically indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric patients aged 1 year and older with ne...
503
Thursday, November 20th, 2025, 13:28
How to Use Selumetinib (Koselugo)
Selumetinib (Koselugo) is a MEK1/2 kinase inhibitor that plays a key role in the treatment of symptomatic, inoperable plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1) in chi...
502
Thursday, November 20th, 2025, 13:07
What is Selumetinib (Koselugo)?
Selumetinib (Koselugo) is a kinase inhibitor primarily used for the treatment of specific types of nervous system tumors. As a targeted therapy drug, its unique pharmacological effects provide an impo...
502
Thursday, November 20th, 2025, 13:04
Side Effects of Ponatinib (Iclusig)
Ponatinib (Iclusig) is a kinase inhibitor that has been approved for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leukemia (CML).Side Ef...
504
Thursday, November 20th, 2025, 13:01
Dosage and Administration of Ponatinib (Iclusig)
Ponatinib (Iclusig) is a potent tyrosine kinase inhibitor that plays a crucial role in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leuk...
503
Thursday, November 20th, 2025, 11:28
What are the Precautions for Taking Ponatinib (Iclusig)?
Ponatinib (Iclusig) is a potent multi-targeted tyrosine kinase inhibitor primarily indicated for the treatment of patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) chronic...
502
Thursday, November 20th, 2025, 11:25
What Are the Purchase Channels for Ponatinib (Iclusig)?
Ponatinib (Iclusig) is a new-generation kinase inhibitor that exhibits unique efficacy in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid l...
503
Thursday, November 20th, 2025, 10:20
What Are the Side Effects of Tukysa (Tucatinib)?
Tukysa (tucatinib) is an oral tyrosine kinase inhibitor primarily used for the treatment of HER2-positive advanced or metastatic breast cancer and colorectal cancer. While it demonstrates significant ...
504
Thursday, November 20th, 2025, 10:13
Precautions for Taking Tucatinib (Tukysa)
Tucatinib (Tukysa) is a highly selective HER2 tyrosine kinase inhibitor. It is indicated for use in combination with trastuzumab and capecitabine for the treatment of advanced HER2-positive breast can...
503
Thursday, November 20th, 2025, 10:01
How to Use Tucatinib (Tukysa)
Tucatinib (Tukysa) is a highly selective HER2 tyrosine kinase inhibitor that has demonstrated significant value in the treatment of advanced HER2-positive breast cancer and colorectal cancer.How to Us...
504
Thursday, November 20th, 2025, 09:59
27 / 184
1837 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved